METTL17 knockdown sensitizes CRC cells to radiotherapy by impairing mitochondrial RNA methylation, which disrupts mitochondrial protein synthesis and exacerbates lipid peroxidation and ROS accumulation. The gene discussed is METTL17; the disease is colorectal carcinoma.